[Secondary hypogonadism].
Takada
Shingo
S
Department of Urology, Osaka University Graduate School of Medicine.
Miyagawa
Yasushi
Y
Okuyama
Akihiko
A
D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D005474:Fluoxymesterone / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007248:Infertility, Male / Q000209:etiology / Q000628:therapy; D007985:Leydig Cells / Q000378:metabolism; D007986:Luteinizing Hormone / Q000502:physiology; D008297:Male; D008596:Menotropins / Q000627:therapeutic use; D011379:Prognosis; D027724:Reproductive Techniques, Assisted; D013739:Testosterone / Q000172:deficiency / Q000378:metabolism / Q000502:physiology
D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D008596:Menotropins; D007986:Luteinizing Hormone; D005474:Fluoxymesterone